LFCR·514766104·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
LFCR (LIFECORE BIOMEDICAL INC) is held by 53 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($7M), GEODE CAPITAL MANAGEMENT, LLC ($3M), MORGAN STANLEY ($2.8M). Net institutional sentiment: Mixed.
See how LFCR's score breaks down across 4 SEC sources
Showing 1-20 of 61
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer